First-in-man fully leadless transvenous CRT-P with a transseptal implant of WISE-CRT® system and Micra® PM.
Elisabetta MontemerloMattia PozziSergio De CegliaFrancesca SantiniElena PiazziGiovanni RovarisPublished in: Pacing and clinical electrophysiology : PACE (2019)
We describe the world's first fully leadless cardiac resynchronization therapy pacing implant with transseptal approach, in a patient with pacemaker dependency, atrial fibrillation, ischemic hypokinetic cardiomyopathy, and a history of pocket infections. After lead extraction, we implanted a MicraTranscathether Pacing System® (Medtronic, Minneapolis, MN, USA) as the sole right ventricular pacemaker, and the WISECRT system (EBR Systems, Sunnyvale, CA, USA) to provide biventricular pacing. We performed the WISECRT implant procedure using the transseptal approach given the presence of a prosthetic aortic mechanical valve, achieving satisfactory periprocedural results.
Keyphrases
- cardiac resynchronization therapy
- heart failure
- left ventricular
- soft tissue
- atrial fibrillation
- aortic valve
- left atrial
- mitral valve
- aortic stenosis
- catheter ablation
- direct oral anticoagulants
- percutaneous coronary intervention
- vena cava
- air pollution
- case report
- venous thromboembolism
- particulate matter
- coronary artery disease
- left atrial appendage
- coronary artery
- pulmonary artery
- oxidative stress
- ejection fraction
- risk assessment